Lovegra Oral Jelly

Lovegra Oral Jelly (Female Sildenafil Citrate 100 mg Jelly) - Product Information

Lovegra Oral Jelly (Female Sildenafil Citrate Jelly) has been specially formulated by Ajanta Pharma Limited, India as a quick acting medication for treating sexual dysfunction in women. Lovegra jelly is manufactured in the strengths of 100 mg of Sildenafil Citrate.
We also have in stock Alphagra tablets (Generic Sildenafil Citrate) which which is used to treat erectile dysfunction in men.

Name of the Drug

Lovegra Oral Jelly.

Manufacturer of  Lovegra Oral Jelly

Ajanta Pharma Limited, India  
Website: www.ajantapharma.com

Active Pharmaceutical Ingredient

The active ingredient present in Lovegra Oral Jelly is Sildenafil Citrate. Each sachet of Lovegra oral jelly contains 100 mg of Sildenafil.

Uses of Lovegra Oral Jelly

Sildenafil citrate, primarily known as Viagra for erectile dysfunction in men, has shown promise in treating female sexual arousal disorder (FSAD). Studies suggest it can improve sexual arousal, desire, and orgasm in women, particularly those without concomitant hypoactive sexual desire disorder (HSDD).

Lovegra Oral Jelly - Dosage

Generic Female Sildenafil Citrate jelly should be administered exactly as suggested by your doctor. Your doctor may recommend a dosage of Lovegra oral jelly depending on your age, medical requirement, body weight, other medical conditions, and current medications.
Use one sachet of Lovegra Oral jelly (Female Sildenafil Citrate 100 mg) as and when required, approximately half an hour to one hour before sexual activity. The maximum recommended dosing frequency is one sachet of Lovegra Oral Jelly (Female Sildenafil Citrate gel) per day. In other words, you can take another dose only if 24 hours have passed since your last dose.
Please consult your doctor for exact dosing instructions. Lovegra oral jelly (Generic Female Sildenafil Citrate jelly) should be administered in the dose prescribed by the doctor and for the duration recommended by the doctor.

Missed Dose

Lovegra oral jelly is administered on a need-basis before participating in sexual activity.
A case of missed dose does not occur in such a treatment schedule.

Female Sildenafil Citrate - Mechanism of Action

Preclinical studies have shown that phosphodiesterase type-5 is present in vaginal, clitoral, and labial smooth muscle. This suggests that PDE5 is involved in female sexual function, particularly genital arousal.
Sildenafil works by increasing blood flow to the genitals, which is similar to how it treats erectile dysfunction in men. This increased blood flow can enhance sexual arousal and sensation. That may help increase sensitivity, arousal, and orgasmic function.

Storage Instructions for Lovegra Oral Jelly

Store Lovegra oral jelly at controlled room temperature (20°C to 25°C),protected from heat, moisture, and sunlight. Excursions are permitted from 15°C to 30°C.
Retain the original packing of the medication and do not consume past its expiration date printed on the blister pack. Keep the pack of Lovegra oral jelly away from the reach of children and pets. Do not dispose along with domestic waste or sewage. Consult your doctor or pharmacist about the correct method of disposal.

Contraindications

Lovegra oral jelly is contraindicated in patients with a hypersensitivity to Sildenafil Citrate or any inactive ingredient present in Lovegra oral jelly. Lovegra oral jelly is contraindicated in the following cases:
Administration of Lovegra oral jelly to patients using nitric oxide donors, such as organic nitrates or organic nitrites in any form. Lovegra oral jelly was shown to potentiate the hypotensive effect of nitrates.
Administration with guanylate cyclase (GC) stimulators, such as Riociguat is also contraindicated.

Overdose

In studies with healthy volunteers of single doses up to 800 mg, adverse events were similar to those seen at lower doses but rates and severities were increased.
In cases of overdose, standard supportive measures should be adopted as required. Renal dialysis is not expected to accelerate clearance as sildenafil is highly bound to plasma proteins and it is not eliminated in the urine.

Warnings and Precautions

• Patients should not use Lovegra oral jelly if sexual activity is inadvisable due to cardiovascular status
• Patients should stop Lovegra oral jelly and seek medical care if a sudden loss of vision occurs in one or both eyes, which could be a sign of non arteritic anterior ischemic optic neuropathy (NAION). Lovegra oral jelly should be used with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Patients with a "crowded" optic disc may also be at an increased risk of NAION.
• Patients should stop Lovegra oral jelly and seek prompt medical attention in the event of sudden decrease or loss of hearing
• Caution is advised when Lovegra oral jelly is co-administered with alpha-blockers or anti-hypertensives. Concomitant use may lead to hypotension
• Decreased blood pressure, syncope, and prolonged erection may occur at higher sildenafil exposures. In patients taking strong CYP inhibitors, such as ritonavir, sildenafil exposure is increased. Decrease in Lovegra oral jelly dosage is recommended

Side Effects of Female Sildenafil Citrate Jelly (Lovegra Oral Jelly)

Most common Sildenafil Citrate side effects with an incidence rate of 2% or more include headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness and rash
For females who do take Sildenafil (Lovegra Oral Jelly), common side effects may overlap with those reported when the medication is taken for ED. Side effects may include: Headache, Flushing (red skin), Stuffy nose, Nausea and Visual disturbances.
The following events occurred in less than 2% of patients in controlled clinical trials; a causal relationship to Sildenafil Citrate (Lovegra Oral Jelly) is uncertain.

• Body as a Whole: face edema, photosensitivity reaction, shock, asthenia, pain, chills, accidental fall, abdominal pain, allergic reaction, chest pain, accidental injury.
• Cardiovascular:angina pectoris, AV block, migraine, syncope, tachycardia, palpitation, hypotension, postural hypotension, myocardial ischemia, cerebral thrombosis, cardiac arrest, heart failure, abnormal electrocardiogram, cardiomyopathy.
• Digestive: vomiting, glossitis, colitis, dysphagia, gastritis, gastroenteritis, esophagitis, stomatitis, dry mouth, liver function tests abnormal, rectal hemorrhage, gingivitis.
• Hemic and Lymphatic: anemia and leukopenia.
• Metabolic and Nutritional: thirst, edema, gout, unstable diabetes, hyperglycemia, peripheral edema, hyperuricemia, hypoglycemic reaction, hypernatremia.
• Musculoskeletal: arthritis, arthrosis, myalgia, tendon rupture, tenosynovitis, bone pain, myasthenia, synovitis.
• Nervous: ataxia, hypertonia, neuralgia, neuropathy, paresthesia, tremor, vertigo, depression, insomnia, somnolence, abnormal dreams, reflexes decreased, hypesthesia.
• Respiratory: asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased.
• Skin and Appendages: urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis.
• Special Senses: sudden decrease or loss of hearing, mydriasis, conjunctivitis, photophobia, tinnitus, eye pain, ear pain, eye hemorrhage, cataract, dry eyes.
• Urogenital: cystitis, nocturia, urinary frequency, breast enlargement, urinary incontinence, abnormal ejaculation, genital edema and anorgasmia.

Sildenafil Citrate (Lovegra Oral Jelly) During Pregnancy

Sildenafil Citrate has been classified by the US FDA as Pregnancy Category B.
Animal reproduction studies conducted with Sildenafil Citrate (Lovegra Oral Jelly) did not show adverse developmental outcomes when administered during organogenesis in rats and rabbits at oral doses up to 16 and 32 times, respectively, the maximum recommended human dose (MRHD) of 100 mg/day on a mg/m2 basis. No evidence of teratogenicity, embryotoxicity or fetotoxicity was observed in rats and rabbits which received oral doses up to 200 mg/kg/day during organogenesis. These doses represent, respectively, about 16 and 32 times the MRHD on a mg/m2 basis in a 50 kg subject. In the rat pre- and postnatal development study, the no observed adverse effect dose was 30 mg/kg/day given for 36 days, about 2 times the MRHD on a mg/m2 basis in a 50 kg subject.
Limited published data from randomized controlled trials, case-controlled trials, and case series do not report a clear association with sildenafil and major birth defects, miscarriage, or adverse maternal or fetal outcomes when Sildenafil is used during pregnancy.
Do not use this medicine without your doctor's consent in case you are pregnant. Stop using this medication and inform your doctor immediately if you become pregnant during treatment.
Do not use this medication without telling your doctor if you are breast-feeding a baby.

Buy Lovegra Oral Jelly Online From Only $1.27 per Sachet

You can buy Female Sildenafil Citrate Jelly online from Everest Online Pharmacy at a cheap price. Lovegra Oral Jelly 5g sachets containing 100 mg of Sildenafil, manufactured by Ajanta Pharma Limited, India, are supplied in a box of 7 sachets. The 100 mg sachets cost only $1.27 per unit when you place an order for 630 sachets.

Disclaimer

The above information is provided to the best of our knowledge and in good faith. It is without a warrant of any kind, expressed or implied.

Shipping Restriction